What is Generex Biotechnology 6-1 Month Momentum %?
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-07), Generex Biotechnology's 6-1 Month Momentum % is -93.33%.
The industry rank for Generex Biotechnology's 6-1 Month Momentum % or its related term are showing as below:
GNBTQ's 6-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -0.63
vs GNBTQ: -93.33
Competitive Comparison of Generex Biotechnology's 6-1 Month Momentum %
For the Biotechnology subindustry, Generex Biotechnology's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Generex Biotechnology's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Generex Biotechnology's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Generex Biotechnology's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Generex Biotechnology 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Generex Biotechnology's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Generex Biotechnology (Generex Biotechnology) Business Description
Generex Biotechnology Corp is a Biotechnology company which is primarily engaged in the research and development of drug delivery systems and technologies. It mainly focuses on developing technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator. The company operates in the single segment being the Research and development of drug delivery systems and technologies for metabolic and immunological diseases. In addition, the company engages in developing proprietary vaccine formulations through its subsidiaries that work by stimulating the immune system to either attack offending agents that is cancer cells, bacteria, and viruses or to stop attacking benign elements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GNBTQ has been successfully added to your